# Citations for Research Query

**Query:** # Mechanistic Hypothesis Search

You are evaluating a specific disease mechanism hypothesis for the Disorder
Mechanisms Knowledge Base. This is not a general disease overview. Use the
hypothesis YAML below as the seed claim, then search for evidence that supports,
refutes, qualifies, or competes with this hypothesis.

## Target Disease
- **Disease Name:** Idiopathic Pulmonary Fibrosis
- **Category:** Respiratory Disease

## Target Hypothesis
- **Hypothesis ID:** senescence_first_model
- **Hypothesis Label:** Senescence-First (Stem-Cell Exhaustion) Model
- **Status in KB:** ALTERNATIVE

## Seed Hypothesis YAML

```yaml
hypothesis_group_id: senescence_first_model
hypothesis_label: Senescence-First (Stem-Cell Exhaustion) Model
status: ALTERNATIVE
description: Age-related and genetically accelerated AT2 cell telomere attrition renders the alveolar
  epithelium incapable of normal repair; any injury triggers SASP rather than regeneration. In this model,
  IPF is fundamentally a stem-cell exhaustion disease in which senescent AT2 cells act as autonomous profibrotic
  drivers through autocrine TGF-beta feedback — even in the absence of ongoing immune activation.
evidence:
- reference: PMID:37653024
  reference_title: Autocrine TGF-β-positive feedback in profibrotic AT2-lineage cells plays a crucial
    role in non-inflammatory lung fibrogenesis.
  supports: SUPPORT
  evidence_source: MODEL_ORGANISM
  snippet: the autocrine TGF-β-positive feedback loop in AT2-lineage cells is a critical cellular system
    in non-inflammatory lung fibrogenesis.
  explanation: Demonstrates that AT2 cell senescence and autocrine TGF-beta are sufficient for fibrogenesis
    without immune involvement, consistent with the senescence-first model.
- reference: PMID:33808277
  reference_title: Telomeres in Interstitial Lung Disease.
  supports: SUPPORT
  evidence_source: OTHER
  snippet: Loss of regenerative potential of alveolar type II epithelial cells (AT2) cells following injury
    has been postulated to underlie telomeropathy-associated lung fibrosis, with concomitant excessive
    proliferation of airway cells displaying abnormal phenotypes
  explanation: Review describes telomere-driven loss of AT2 regenerative capacity as a mechanistic explanation
    for the strong age and telomere-length associations in IPF.
notes: Supported by the exponential age-dependence of IPF, by telomere gene mutations in familial IPF
  causing earlier onset, and by the Enomoto 2023 organoid model showing immune-independent fibrogenesis.
  However, this model alone does not explain why fibrosis is patchy or why some individuals with short
  telomeres do not develop IPF without injury.
```

## Research Objective

Build a focused hypothesis-search report that answers:

1. What is the strongest direct evidence for this hypothesis?
2. What evidence argues against it, fails to reproduce it, or limits its scope?
3. Which claims are established, emerging, speculative, or contradicted?
4. Which patient subtypes, stages, tissues, cell types, molecular pathways, or
   biomarkers does the hypothesis best explain?
5. Which alternative or competing mechanistic hypotheses explain the same disease
   features better or more parsimoniously?
6. What are the explicit knowledge gaps: missing causal steps, unconfirmed edges,
   contradictory evidence, unknown source-to-target links, or source/data absences?
7. What experiments, cohorts, assays, datasets, or trials would most directly
   distinguish this hypothesis from alternatives?

Use primary literature whenever possible. Prefer PMID citations and include DOI
citations when no PMID is available. Treat reviews as orientation unless they
contain directly relevant synthesized evidence that should be clearly labeled as
review-level support.

## Required Output

### Executive Judgment

Give a concise verdict on the hypothesis as of the current literature:
supported, partially supported, unresolved, weakly supported, or refuted. Explain
the reasoning and the most important caveats.

### Evidence Matrix

Create a table with one row per important evidence item:

- Citation (PMID preferred)
- Evidence type (human clinical, model organism, in vitro, computational, review)
- Supports / refutes / qualifies / competing
- Mechanistic claim tested
- Key finding
- Disease subtype or context
- Confidence and limitations

### Mechanistic Causal Chain

Describe the causal chain implied by the hypothesis from upstream trigger to
clinical manifestation. Identify where the literature is strong, where the links
are inferred, and where there are missing causal steps.

### Knowledge Gaps

Identify explicit known unknowns surfaced by the search. Treat absence of
evidence as a curation-relevant finding only when the search actually checked for
it. Include:

- Unknown or weakly supported causal steps in the hypothesis
- Unconfirmed causal graph edges that need direct perturbation or longitudinal
  evidence
- Conflicting evidence, failed replications, or incompatible subtype-specific
  findings
- Unknown mechanism of action for relevant treatments, biomarkers, or
  interventions tied to this hypothesis
- Source-level or dataset-level absences, such as no relevant GenCC, ClinGen,
  trial, omics, or cohort evidence found as of the search date

For each gap, state the scope, why it matters, what was checked, and what
evidence or experiment would resolve it.

### Alternative Models

List competing or complementary hypotheses. For each, explain whether it is an
alternative to the seed hypothesis, a downstream consequence, an upstream cause,
or a parallel mechanism.

### Discriminating Tests

Recommend concrete studies or assays that would most efficiently test this
hypothesis against alternatives. Include patient stratification, biomarkers,
sample type, model system, perturbation, and expected result where applicable.

### Curation Leads

Provide candidate updates for the KB, but label these as leads requiring curator
verification. Include:

- candidate evidence references and exact abstract snippets to verify
- candidate pathophysiology nodes or edges
- candidate ontology terms for cell types and biological processes
- candidate subtype restrictions or status changes
- candidate `knowledge_gaps` or discussion prompts for unresolved causal claims,
  conflicting evidence, or explicit source/data absences

If the provider supports artifacts, produce artifact-friendly outputs such as an
evidence matrix, mechanistic diagram, knowledge-gap table, or comparison table.
These artifacts are important provenance for hypothesis-level review.

**Provider:** openscientist
**Generated:** 2026-07-06T08:51:02.976081

1. PMID:37653024
2. PMID:32832599
3. PMID:42388797
4. PMID:34969962
5. PMID:24718857
6. PMID:31962055
7. PMID:41764163
8. PMID:34386777
9. PMID:30616998
10. PMID:36857968
11. PMID:31542391
12. PMID:30560893
13. PMID:31000627
14. PMID:34831112
15. PMID:31922885
16. PMID:32253243
17. PMID:37771586
18. PMID:39927460
19. PMID:42182417
20. PMID:18390830
21. PMID:23926107
22. PMID:21670280
23. PMID:23268535
24. PMID:31432710
25. PMID:41728098
26. PMID:30320420
27. PMID:30067250
28. PMID:34524912
29. PMID:42376016
30. PMID:32109549
31. PMID:34377373
32. PMID:12707032
33. PMID:35879310
34. PMID:40769983
35. PMID:33197388
36. PMID:37170112
37. PMID:38958042
38. PMID:39970931
39. PMID:41624889
40. PMID:39846634
41. PMID:40675771